XML 79 R67.htm IDEA: XBRL DOCUMENT v3.19.2
Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Payables and Accruals [Abstract]    
Commercial rebates, fees and returns $ 107,919 $ 80,520
Milestone payment for FDA approval of Vyleesi 60,000 0
Professional, license, and other fees and expenses 23,663 23,242
Salaries, bonuses, and other compensation 16,674 22,482
Interest expense 3,311 2,226
Research and development expense 867 1,067
Restructuring expense 1,777 0
Total accrued expenses $ 214,211 $ 129,537